Literature DB >> 17280904

Tuberculosis chemotherapy: recent developments and future perspectives.

Veemal Bhowruth1, Lynn G Dover, Gurdyal S Besra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280904     DOI: 10.1016/S0079-6468(06)45504-1

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  5 in total

1.  Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology.

Authors:  Bhargava Sai Allaka; Srinivas Basavoju; Estharla Madhu Rekha; Dharmarajan Sriram; Gamidi Rama Krishna
Journal:  Mol Divers       Date:  2022-08-06       Impact factor: 3.364

2.  Antibacterial, Antitubercular and Antiviral Activity Evaluations of Some Arylidenehydrazide Derivatives Bearing Imidazo[2,1-b]thiazole Moiety.

Authors:  Nuray Ulusoy Güzeldemirci; Berin Karaman; Ömer Küçükbasmaci
Journal:  Turk J Pharm Sci       Date:  2017-08-15

Review 3.  Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction.

Authors:  Arun K Mishra; Nicole N Driessen; Ben J Appelmelk; Gurdyal S Besra
Journal:  FEMS Microbiol Rev       Date:  2011-05-31       Impact factor: 16.408

4.  Synthesis and Antimycobacterial Activity of 2-(Phenylthio) benzoylarylhydrazone Derivatives.

Authors:  Ali Almasirad; Somayeh Samiee-Sadr; Abbas Shafiee
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

5.  Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity.

Authors:  Corina Popovici; Cristina-Maria Pavel; Valeriu Sunel; Corina Cheptea; Dan Gheorghe Dimitriu; Dana Ortansa Dorohoi; Diana David; Valentina Closca; Marcel Popa
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.